Johnson & Johnson
JNJ
$149.56
Share price
0.30%
Change (1 day)
-8.63%
Change (1 year)
Categories
Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.
Johnson & Johnson (JNJ) - P/B ratio
P/B ratio as of April 2024 : 5.24
According to Johnson & Johnson's latest financial reports the company has a price-to-book ratio of 5.24.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Johnson & Johnson - P/B ratio (from 2001 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 5.49 | -8.76% |
| 2022-12-31 | 6.01 | -1.16% |
| 2021-12-31 | 6.08 | -7.08% |
| 2020-12-31 | 6.55 | 1.4% |
| 2019-12-31 | 6.46 | 12.3% |
| 2018-12-31 | 5.75 | -7.84% |
| 2017-12-31 | 6.24 | 40.18% |
| 2016-12-31 | 4.45 | 11.42% |
| 2015-12-31 | 3.99 | -4.26% |
| 2014-12-31 | 4.17 | 19.6% |
| 2013-12-31 | 3.49 | 16.11% |
| 2012-12-31 | 3.00 | -4.24% |
| 2011-12-31 | 3.14 | 4.51% |
| 2010-12-31 | 3.00 | -14.54% |
| 2009-12-31 | 3.51 | -10.04% |
| 2008-12-31 | 3.90 | -10.71% |
| 2007-12-31 | 4.37 | -9.98% |
| 2006-12-31 | 4.86 | 5.2% |
| 2005-12-31 | 4.62 | -22.03% |
| 2004-12-31 | 5.92 | 3.79% |
| 2003-12-31 | 5.71 | -18.76% |
| 2002-12-31 | 7.02 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | 4.29 | -18.19% | 🇨🇭 Switzerland |
 Pfizer PFE | 1.67 | -68.15% | 🇺🇸 USA |
 Abbott Laboratories ABT | 4.81 | -8.25% | 🇺🇸 USA |
 Medtronic MDT | 2.08 | -60.39% | 🇮🇪 Ireland |
 Eli Lilly LLY | 65.3 | 1,145.33% | 🇺🇸 USA |
 Sanofi SNY | 1.45 | -72.36% | 🇫🇷 France |
 Gilead Sciences GILD | 3.67 | -29.89% | 🇺🇸 USA |
 Stryker Corporation SYK | 6.85 | 30.78% | 🇺🇸 USA |
 Merck MRK | 8.54 | 62.96% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 5.17 | -1.29% | 🇬🇧 UK |